Search Login Register

pemetrexed (MTA) Summary

Description: structure given in first source

Also Known As: MTA; ALIMTA; pemetrexed disodium; LY231514; LY 231,514 Show All >>

Networked: 1858 relevant articles (246 outcomes, 673 trials/studies) for this Drug

Key Diseases for which pemetrexed is Relevant

  1. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) : 104 outcomes 245 studies in 567 results
  2. Mesothelioma : 47 outcomes 89 studies in 314 results
  3. Neoplasms (Cancer) : 28 outcomes 116 studies in 406 results
  4. Lung Neoplasms (Lung Cancer) : 13 outcomes 23 studies in 109 results
  5. Adenocarcinoma : 12 outcomes 14 studies in 68 results
Show All >>

Drugs Related to pemetrexed

  1. Cisplatin (Platino)
  2. Platinum
  3. gemcitabine
  4. Carboplatin (JM8)
  5. bevacizumab
  6. docetaxel (Taxotere)
  7. pemetrexed (MTA)
  8. erlotinib (CP 358,774)
  9. oxaliplatin (Eloxatin)
  10. gefitinib (Iressa)
Show All >>

Therapies Related to pemetrexed

  1. Drug Therapy (Chemotherapy)
  2. Combined Modality Therapy
  3. Heterologous Transplantation (Xenotransplantation)
  4. Pulpotomy
  5. Pneumonectomy (Lung Volume Reduction)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.